Funding · Company
Magnus Medical, Inc.
Burlingame, CABiotech & Pharma
Magnus Medical, Inc. of Burlingame, CA has disclosed $89M across 2 Form D offerings filed with the SEC between Mar 14, 2025 and May 26, 2026.
$89M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$49M
Form D · May 26, 2026 ↗
Q2 2026
· 1 amendment, first filed May 12, 2025
· target $77M
$40M
Form D · Mar 14, 2025 ↗
Q1 2025
· target $59M
Filing details
HeadquartersBurlingame, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0002057312Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →